Fujisawa Pharmaceutical Company Limited Company Profile

12:25 EDT 26th September 2017 | BioPortfolio

Antibiotics Veterinary


2-10 Nihonbashi Hon-cho 2-chome Chuo-ku


Phone: 81 3 3279 0871
Fax: 81 3 3241 0722

News Articles [1670 Associated News Articles listed on BioPortfolio]

Aoxing Pharmaceutical Company, Inc.: Aoxing Pharmaceutical Announces Delisting and Deregistration of Common Stock

FOSTER CITY, CA / ACCESSWIRE / September 25, 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE American: AXN) today announced that its board of directors has made a determination to remove the Aoxin...

Takeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Takeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance ReportSummaryTakeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensiv...

M Pharmaceutical, Inc.: M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services to Develop Regulatory Strategy for Recently Patented Extrinsa for the Treatment of Female Sexual Dysfunction

CINCINNATI, OH / ACCESSWIRE / June 2, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutic...

Oasmia Pharmaceutical AB: Issuance of warrants in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (the "Company") resolved, at the Extraordinary General Meeting of the Company on 2 June 2017, to establish two warrant programmes, series 2017:1 and series 2017:2, i...

BioSyent Schedules Q1 2017 Earnings Release for May 25, 2017

TORONTO, ONTARIO -- (Marketwired) -- 05/16/17 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) will be reporting its financial results for the three months ended March 31, 2017 on Thursday, May 25, 2...

Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda

NANJING, China, June 24, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufac...

CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.

OXNARD, Calif., May 24, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development ...

BioSyent Releases Q1 2017 Results

TORONTO, ONTARIO -- (Marketwired) -- 05/25/17 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) released today a summary of its financial results for the three months ended March 31, 2017. Key highlig...

PubMed Articles [504 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?

Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...

Clinical Trials [313 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

This study compared the relative bioavailability (rate and extent of absorption) of Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of Pravachol® Tablet...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Companies [2887 Associated Companies listed on BioPortfolio]

Fujisawa Pharmaceutical Company Limited

Antibiotics Veterinary

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Astellas Pharma US,Inc

Launched in April 2005, Astellas was formed by the historical merger of Japan's third and fifth largest pharmaceutical companies - Yamanouchi, founded in 1923, and Fujisawa, founded in 1894.Both compa...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Starpharma Holdings Ltd

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharma...

More Information about "Fujisawa Pharmaceutical Company Limited" on BioPortfolio

We have published hundreds of Fujisawa Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Fujisawa Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Fujisawa Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fujisawa Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Fujisawa Pharmaceutical Company Limited Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record